Literature DB >> 17485229

Copper induces permeability transition through its interaction with the adenine nucleotide translocase.

Noemí García1, Eduardo Martínez-Abundis, Natalia Pavón, Francisco Correa, Edmundo Chávez.   

Abstract

In this work we examined the effect of low concentrations of Cu(2+) on the opening of the mitochondrial non-specific pore. The purpose was addressed to further contribute to the knowledge of the mechanisms that regulate the open/closed cycles of the permeability transition pore. Membrane leakage was established by measuring matrix Ca(2+) efflux and mitochondrial swelling. The experimental results indicate that Cu(2+) at very low concentrations promoted the release of accumulated Ca(2+), as well as mitochondrial swelling, provided 1,10-phenanthroline has been added. Carboxyatractyloside and Cu(2+) exhibited additive effects on these parameters. After Cu(2+) titration of membrane thiols, it might be assumed that the blockage of 5.9nmol of SH/mg protein suffices to open the non-specific pore. Taking into account the reinforcing effect of carboxyatractyloside, the increasing ADP concentrations, and that N-ethylmaleimide inhibited the Cu(2+)-induced Ca(2+) efflux, it is proposed that the target site for Cu(2+) is located in the ADP/ATP carrier.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485229     DOI: 10.1016/j.cellbi.2007.02.003

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  9 in total

Review 1.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

2.  Antineoplastic copper coordinated complexes (Casiopeinas) uncouple oxidative phosphorylation and induce mitochondrial permeability transition in cardiac mitochondria and cardiomyocytes.

Authors:  Christian Silva-Platas; Carlos Enrique Guerrero-Beltrán; Mariana Carrancá; Elena Cristina Castillo; Judith Bernal-Ramírez; Yuriana Oropeza-Almazán; Lorena N González; Rocío Rojo; Luis Enrique Martínez; Juan Valiente-Banuet; Lena Ruiz-Azuara; María Elena Bravo-Gómez; Noemí García; Karla Carvajal; Gerardo García-Rivas
Journal:  J Bioenerg Biomembr       Date:  2016-01-07       Impact factor: 2.945

Review 3.  The still uncertain identity of the channel-forming unit(s) of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines; Manuel Gutiérrez-Aguilar
Journal:  Cell Calcium       Date:  2018-05-16       Impact factor: 6.817

Review 4.  Mitochondrial pathobiology in ALS.

Authors:  Lee J Martin
Journal:  J Bioenerg Biomembr       Date:  2011-12       Impact factor: 2.945

5.  Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.

Authors:  Lee J Martin
Journal:  Pharmaceuticals (Basel)       Date:  2010

Review 6.  Biology of mitochondria in neurodegenerative diseases.

Authors:  Lee J Martin
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

7.  The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.

Authors:  Lee J Martin; Barry Gertz; Yan Pan; Ann C Price; Jeffery D Molkentin; Qing Chang
Journal:  Exp Neurol       Date:  2009-03-09       Impact factor: 5.330

Review 8.  The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.

Authors:  Lee J Martin
Journal:  Biochim Biophys Acta       Date:  2009-08-03

9.  Ex Vivo Cardiotoxicity of Antineoplastic Casiopeinas Is Mediated through Energetic Dysfunction and Triggered Mitochondrial-Dependent Apoptosis.

Authors:  Christian Silva-Platas; César A Villegas; Yuriana Oropeza-Almazán; Mariana Carrancá; Alejandro Torres-Quintanilla; Omar Lozano; Javier Valero-Elizondo; Elena C Castillo; Judith Bernal-Ramírez; Evaristo Fernández-Sada; Luis F Vega; Niria Treviño-Saldaña; Héctor Chapoy-Villanueva; Lena Ruiz-Azuara; Carmen Hernández-Brenes; Leticia Elizondo-Montemayor; Carlos E Guerrero-Beltrán; Karla Carvajal; María E Bravo-Gómez; Gerardo García-Rivas
Journal:  Oxid Med Cell Longev       Date:  2018-03-25       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.